RDY DR REDDYS LABORATORIES LTD
NEUTRAL
Impact: 3/10
6-K
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
RDY ▲ +3.54% at T+5d
NEUTRAL call ✓ call won +3.54% · α vs SPY +4.70% · entry $12.99 → $13.45
Currently $13.30 · +2.39% from $12.99 entry
T+1d
0.00%
call 0.00% · α +0.00%
$12.99
settled 4w ago
T+5d
+3.54%
call +3.54% · α +4.70%
$13.45
settled 25d ago
T+20d
—
call — · α —
—
due 3d ago
T+60d
—
call — · α —
—
in 8w
Price Chart
Loading chart...
Executive Summary
Dr. Reddy's Laboratories filed its Q4 FY26 audited financial results presentation via a 6-K on May 12, 2026. The filing is a routine earnings disclosure with no specific financial figures or guidance provided in the document text, making the material impact unclear.
Actionable Insight
The filing lacks extractable financial data. Monitor for a subsequent press release or analyst call for actual Q4 results and forward guidance.
Key Facts
- Filed Q4 FY26 audited financial results presentation under Regulation 30 of SEBI Listing Regulations
- Filing date: May 12, 2026
- No specific financial figures (revenue, EPS, margins) or guidance were disclosed in the filing text
- Document content consists of a cover letter and graphic images of the presentation, not extractable text
Financial Impact
No financial figures available in the filing text
Risk Factors
- No quantitative data to assess performance
- Potential for negative surprise if results are weak
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
50% bullish (44 analysts)
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000303 |
| Document: 0001575872-26-000303-index.html | 0001575872-26-000303 |
| Document: 0001575872-26-000303.txt | 0001575872-26-000303 |
23 reports for RDY
33%
Hit rate
best @ T+5▲ +0.07%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
2d ago
|
6-K
| $13.45 awaiting T+1 | awaiting T+1 | — | $13.30 (−1.08%) |
|
Jun 5, 2026
7d ago
|
6-K
| $13.29 awaiting T+1 | awaiting T+1 | — | $13.30 (+0.11%) |
|
Jun 3, 2026
10d ago
|
6-K
| $13.02 $13.24 | ▲ +1.69% | ▲ +1.29% | $13.30 (+2.15%) |
|
Jun 1, 2026
12d ago
|
6-K
| $13.26 $13.03 | ▼ −1.73% | ▼ −1.88% | $13.30 (+0.30%) |
|
Jun 1, 2026
12d ago
|
6-K
| $13.26 $13.03 | ▼ −1.73% | ▼ −1.88% | $13.30 (+0.30%) |
|
May 29, 2026
14d ago
|
20-F
| $13.26 $13.03 | ▼ −1.73% | ▼ −1.88% | $13.30 (+0.30%) |
|
May 28, 2026
15d ago
|
6-K
| $13.52 $13.63 | ▲ +0.81% | ▲ +0.57% | $13.30 (−1.63%) |
|
May 28, 2026
16d ago
|
6-K
| $13.52 $13.63 | ▲ +0.81% | ▲ +0.57% | $13.30 (−1.63%) |
|
May 18, 2026
25d ago
|
6-K
| $13.60 $13.45 | ▼ −1.10% | ▼ −0.45% | $13.30 (−2.21%) |
|
May 18, 2026
26d ago
|
6-K
| $13.60 $13.45 | ▼ −1.10% | ▼ −0.45% | $13.30 (−2.21%) |
Showing 10 of 23
US Market Status
Market Closed — Opens Mon (48h 54m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access